Off-target effects in CRISPR/Cas9 gene editing
Open accessThe DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index; 151 of the 237 sources its claims cite were checked for support.
Abstract
Gene editing stands for the methods to precisely make changes to a specific nucleic acid sequence. With the recent development of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system, gene editing has become efficient, convenient and programmable, leading to promising translational studies and clinical trials for both genetic and non-genetic diseases. A major concern in the applications of the CRISPR/Cas9 system is about its off-target effects, namely the deposition of unexpected, unwanted, or even adverse alterations to the genome. To date, many methods have been developed to nominate or detect the off-target sites of CRISPR/Cas9, which laid the basis for the successful upgrades of CRISPR/Cas9 derivatives with enhanced precision. In this review, we summarize these technological advancements and discuss about the current challenges in the management of off-target effects for future gene therapy.
Overview
CoChat Summary
TL;DR
This review summarizes methods for predicting and detecting CRISPR/Cas9 off-target effects and strategies for improving editing specificity. It emphasizes persistent trade-offs between accuracy and sensitivity and the difficulty of assessing off-target effects in vivo and in patients.
Key findings
- Off-target effects remain a major challenge for CRISPR/Cas9; Cas9 tolerates up to 3 mismatches between sgRNA and genomic DNA, and sgRNA-independent off-target effects also occur.
- In silico tools are convenient but biased toward sgRNA-dependent off-target effects and require experimental validation; examples include CasOT, Cas-OFFinder, FlashFry, Crisflash, MIT, CCTop, CROP-IT, CFD, DeepCRISPR, and Elevation.
- Experimental detection methods vary widely: Digenome-seq detects indels at 0.1% frequency or lower but needs ∼400–500 million reads for the human genome; SITE-seq needs ∼0.62–2.46 million reads but only 10% of positive hits were validated by targeted sequencing; CIRCLE-seq needs ∼4–5 million reads but has a high false positive rate; GUIDE-seq detects indel frequencies as low as 0.03% but captures only 30%–50% of all DSBs.
- Specificity strategies include high-fidelity Cas9 variants (eSpCas9, SpCas9-HF1, hypaCas9, evoCas9), sgRNA length/chemical modification, DSB-independent base editors, and delivery methods such as RNP electroporation and LNPs; evoCas9, SpCas9-HF1, and eSpCas9 reduced off-target sites by 98.7%, 95.4%, and 94.1%, respectively, in one comparison.
Methods
- This is a narrative review, not a primary experimental study; no original sample, dataset, or systematic meta-analysis is described.
- It synthesizes in silico prediction tools, cell-free, cell culture-based, and in vivo off-target detection methods, plus strategies to reduce off-target effects.
- Main analysis is qualitative comparison of advantages and disadvantages, organized in Tables 1 and 2 and supported by cited literature.
Limitations
- The paper states that limitations remain in balancing accuracy versus sensitivity of off-target detection techniques, and that direct assessment of off-target effects in vivo and in patients is particularly challenging.
- It notes that in silico predictions are biased toward sgRNA-dependent off-target effects and need experimental validation, and that many experimental methods have limitations such as high cost, high sequencing coverage, low sensitivity, false positives, false negatives, or dependence on chromatin accessibility.
- Evident from the text: as a review, it provides no new experimental data, and it states there is currently no standardized approach to confirm the sensitivity of Discover-seq.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
78 Valid · 10 Not valid · 21 Not checked · 25 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Similarly, the Elevation tool also includes DNA accessibility information to predict potential off-target sites (Listgarten et al., 2018).”
§ Off-target effects in CRISPR/Cas9 gene editing > 2 In silico prediction
What the sources say
- Disputedcites Listgarten et al., 2018 matched to “Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs” (2018) sourceExperimental — accuracy not yet measured
The Results section, “Predicting with chromatin accessibility” (page not provided), says the authors tested DNase I accessibility features but decided not to include them in the final deployed Elevation model because the results were inconclusive. Thus, the paper says the tool does not include the information the claim attributes to it. (LLM, conf=0.93)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“A primary limitation of GUIDE-seq is relevant to the low delivery efficiency of dsODNs into cells, which results in detection of only 30%–50% of all the DSBs (Tsai et al., 2015; Pan et al., 2022).”
§ Off-target effects in CRISPR/Cas9 gene editing > 3 Experimental detection > 3.2 Cell culture-based methods
What the sources say
- Disputedcites Tsai et al., 2015 matched to “GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases” (2015) sourceExperimental — accuracy not yet measured
The Results (Overview of the GUIDE-Seq method; page unavailable) report robust dsODN integration, at rates two- to three-fold lower than indel frequencies at the tested sites—not detection of 30%–50% of all DSBs. The Discussion (page unavailable) describes dsODN integration as very efficient and reports detection of 38 of 40 previously identified off-target sites, contrary to the claimed primary limitation. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
- Partly supportedcites Pan et al., 2022 matched to “Massively targeted evaluation of therapeutic CRISPR off-targets in cells” (2022) sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says GUIDE-seq relies on inserting double-stranded DNA at double-strand breaks, and the Results section on SURRO-seq validation likewise describes insertion of a double-stranded oligonucleotide. Neither passage says that delivery into cells is inefficient or that GUIDE-seq detects only 30%–50% of DSBs; searches for those terms found no such estimate in our copy. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“| Delivery methods improvement | Application in cell culture [89–94] | RNP electroporation: Rapid transfection and turnover | Eliminate off-target effects |”
§ Off-target effects in CRISPR/Cas9 gene editing > 4 Strategies to reduce off-target effects > 4.1 Cas9 improvement
What the sources say
- Not checked — no full text of the sourcecites [89] Wang X. Wu Y. Yee J. K. (2021). Detection of CRISPR/Cas9-Generated off-target effect by integration-defective lentiviral vector. Methods Mol. Biol. 2162, 243– 260. 10.1007/978-1-0716-0687-2_14 32926387 source
- Disputedcites [90] Wienert B. Wyman S. K. Richardson C. D. Yeh C. D. Akcakaya P. Porritt M. J. (2019). Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq. Science 364 (6437), 286– 289. 10.1126/science.aav9023 31000663 PMC6589096 sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports editing patient-derived iPSCs with HiFi-Cas9 RNPs and detecting two off-targets with the wild-type guide. That contradicts the claim that RNP delivery eliminates off-target effects; the passage does not specify electroporation or rapid turnover. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [91] Willyard C. (2017). The epigenome editors: How tools such as CRISPR offer new details about epigenetics. Nat. Med. 23 (8), 900– 903. 10.1038/nm0817-900 28777784 source
- Could not verifycites [92] Witzigmann D. Kulkarni J. A. Leung J. Chen S. Cullis P. R. van der Meel R. (2020). Lipid nanoparticle technology for therapeutic gene regulation in the liver. Adv. Drug Deliv. Rev. 159, 344– 363. 10.1016/j.addr.2020.06.026 32622021 PMC7329694 sourceExperimental — accuracy not yet measured
The ‘mRNA for gene expression and genome editing’ section describes lipid-nanoparticle delivery of Cas9-encoding mRNA with sgRNA, including results in mice. Searches for RNP electroporation, rapid turnover, and off-target effects found no passage addressing whether electroporation in cell culture eliminates off-target effects. The available passages therefore do not verify the claim. (LLM, conf=0.74)
- Could not verifycites [93] Wu X. Scott D. A. Kriz A. J. Chiu A. C. Hsu P. D. Dadon D. B. (2014). Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol. 32 (7), 670– 676. 10.1038/nbt.2889 24752079 PMC4145672 sourceExperimental — accuracy not yet measured
The Online Methods (Cell culture) say transfections used Lipofectamine 2000, not RNP electroporation. The Results (One of 295 off-target sites is mutated above background) report an off-target mutation, but do not test whether RNP electroporation eliminates off-target effects. Searches for RNP electroporation and ribonucleoprotein delivery found no passage addressing that claim. (LLM, conf=0.76)
- Could not verifycites [94] Wu Y. Ren Q. Zhong Z. Liu G. Han Y. Bao Y. (2022). Genome-wide analyses of PAM-relaxed Cas9 genome editors reveal substantial off-target effects by ABE8e in rice. Plant Biotechnol. J. 20 (9), 1670– 1682. 10.1111/pbi.13838 35524459 PMC9398351 sourceExperimental — accuracy not yet measured
The Experimental procedures section describes Agrobacterium-mediated transformation of rice calli, not RNP electroporation in cell culture. The Results report off-target mutations from the rice editors studied, but do not test whether RNP electroporation eliminates them. Searches for RNP delivery and electroporation found no passage addressing that claim. (LLM, conf=0.77)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Cas-OFFinder is more widely applicated due to its high tolerance of sgRNA length, PAM types, and the number of mismatches or bulges (Bae et al., 2014).”
§ Off-target effects in CRISPR/Cas9 gene editing > 2 In silico prediction
What the sources say
- Partly supportedcites Bae et al., 2014 matched to “Cas-OFFinder: A fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases” (2014) sourceExperimental — accuracy not yet measured
The Results and Discussion section reports searches using 20-bp and 24-bp guide-matching sequences and different PAMs; its conclusion says Cas-OFFinder does not limit the number of mismatched bases. The Methods section describes counting mismatches, but no passage establishes that the tool tolerates bulges. That part of the claim is unsupported by this copy. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although CRISPR/Cas systems exhibit tremendous potential in translational medicine, off-target effects remain a major challenge (Fu et al., 2013; Hsu et al., 2013; Pacesa et al., 2022).”
§ Off-target effects in CRISPR/Cas9 gene editing > 1 Introduction
What the sources say
- Not matchedcites Fu et al., 2013
This doesn’t read as a citation we can look up.
- Partly supportedcites Hsu et al., 2013 matched to “DNA targeting specificity of RNA-guided Cas9 nucleases” (2013) sourceExperimental — accuracy not yet measured
The paper’s Abstract (page unavailable) documents off-target editing in human cells and describes ways to minimize it, supporting the claim that off-target effects are a challenge for Cas9 genome editing. It does not specifically assess translational medicine or establish how major that challenge is in clinical use. (LLM, conf=0.81)
- Supportedcites Pacesa et al., 2022 matched to “Structural basis for Cas9 off-target activity” (2022) source
The Introduction says that off-target activity of SpCas9 and other Cas9 enzymes presents a safety concern for therapeutic applications. The Discussion also links improved off-target prediction to safer therapeutic use, supporting the cited background claim. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
82 more claims · 52 with their cited sources checked
Create a free account to see all 134 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 33
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Off-target effects are unintended genomic modifications occur when guide RNA (gRNA) binds to sequences similar to, but not identical with, the intended target, potentially resulting in undesirable DNA cleavage and mutations (Guo et al., 2023; Lopes and Prasad, 2024; Garrigues et al., 2023).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Guo et al., 2023
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, recent studies have shown that Cas9 tolerates up to three mismatches between the gRNA and genomic DNA, which increases the chances of off-target effects in regions with higher GC content.”
From Hybrid Neural Networks for Off-Target Prediction in Gene Editing: Integrating Sequence and Biophysical Features (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although CRISPR/Cas9 introduces targeted mutations, it actually supports the maintenance of clonal fidelity by offering precise and controlled gene editing, unlike the random and widespread genetic alterations associated with somaclonal variation [178].”
From Somaclonal Variation and Clonal Fidelity in Commercial Micropropagation: Challenges and Perspectives (2025) · cites this paper as [178]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Off-target effects in CRISPR/Cas9 gene editing > 2 In silico prediction
“| In silico prediction | Alignment based models | CasOT [21] | Adjustable in PAM sequence and the mismatch number (at most 6) | Conveniently accessable via internet | Biased toward sgRNA-dependent off-target effects; results need experimental validation |”
§ Off-target effects in CRISPR/Cas9 gene editing > References
“95. Xiao A. Cheng Z. Kong L. Zhu Z. Lin S. Gao G. (2014). CasOT: A genome-wide cas9/gRNA off-target searching tool.”
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · cited 11×
“Cas-OFFinder is more widely applicated due to its high tolerance of sgRNA length, PAM types, and the number of mismatches or bulges (Bae et al., 2014).”
BackgroundInfluentialMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339 · cited 11×
“Cas-OFFinder is more widely applicated due to its high tolerance of sgRNA length, PAM types, and the number of mismatches or bulges (Bae et al., 2014).”
BackgroundInfluentialProgrammable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437 · cited 1×
“ABE catalyzes the editing from adenine to guanine and CBE converts cytosine to thymine (Komor et al., 2016; Gaudelli et al., 2017; Wu et al., 2022).”
BackgroundDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741 · cited 5×
“The off-target sites are often sgRNA-dependent, since Cas9 is known to tolerate up to 3 mismatches between sgRNA and genomic DNA (Fu et al., 2013; Hsu et al., 2013; Wang et al., 2016a).”
BackgroundInfluentialOptimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637 · cited 2×
“The CFD algorithm is derived from a CRISPR/Cas9 genetic screen experiment that assessed the off-target effects of thousands of sgRNAs (Doench et al., 2016).”
BackgroundMethodProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184 · cited 1×
“ABE catalyzes the editing from adenine to guanine and CBE converts cytosine to thymine (Komor et al., 2016; Gaudelli et al., 2017; Wu et al., 2022).”
BackgroundHigh-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292 · cited 2×
“The off-target sites are often sgRNA-dependent, since Cas9 is known to tolerate up to 3 mismatches between sgRNA and genomic DNA (Fu et al., 2013; Hsu et al., 2013; Wang et al., 2016a).”
BackgroundHigh-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414 · cited 8×
“This idea led to the rational design of SpCas9 mutants such as enhanced SpCas9 (eSpCas9) and SpCas9-HF1 (HF1 for high-fidelity variant #1).”
BackgroundInfluentialBae, S., Park, J., & Kim, J.-S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu048 · Cited by 2,339 · cited 1×
“Cas-OFFinder is more widely applicated due to its high tolerance of sgRNA length, PAM types, and the number of mismatches or bulges (Bae et al., 2014).”
BackgroundGenome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285 · cited 1×
“Early studies utilize zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) for genome editing (Urnov et al., 2010; Joung and Sander, 2013; Shamshirgaran et al., 2022).”
BackgroundGUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268 · cited 8×
“The integrated dsODNs provide templates for targeted PCR amplification and sequencing of the tagged DNA fragments (Tsai et al., 2015; Malinin et al., 2021; Yaish et al., 2022) (Figure 1B).”
BackgroundMethodInfluentialImproving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 2×
“On the other hand, sgRNA truncation by 2-3bp at 5’ end is also reported to decrease off-target effects while maintaining on-target editing efficiency (Fu et al., 2014).”
BackgroundTargeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863 · cited 11×
“Cas-OFFinder is more widely applicated due to its high tolerance of sgRNA length, PAM types, and the number of mismatches or bulges (Bae et al., 2014).”
BackgroundInfluentialKim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856 · cited 1×
“RNP electroporation exhibits higher on-target editing efficiency and lower off-target mutations than the other delivery methods (Kim et al., 2014; Ramakrishna et al., 2014).”
BackgroundCRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107454 · Cited by 1,801
Haeussler, M., Schönig, K., Eckert, H., Eschstruth, A., Mianné, J., Renaud, J.-B., Schneider-Maunoury, S., Shkumatava, A., Teboul, L., Kent, J., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1012-2 · Cited by 1,756 · cited 1×
“The algorithm of MIT weights the position effect of the mismatches in the sgRNA to generate a score to evaluate off-target effects (Hsu et al., 2013; Haeussler et al., 2016).”
TALENs: A widely applicable technology for targeted genome editing
Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650 · cited 1×
“Early studies utilize zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) for genome editing (Urnov et al., 2010; Joung and Sander, 2013; Shamshirgaran et al., 2022).”
BackgroundEngineered CRISPR-Cas9 nucleases with altered PAM specificities
Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, V. V., Nguyen, N. T., Zheng, Z., Gonzales, A. P. W., Li, Z., Peterson, R. T., Yeh, J.-R. J., et al. (2015) · Nature · doi:10.1038/nature14592 · Cited by 1,624 · cited 1×
“This screen identified four key beneficial point mutations in SpCas9, giving rise to evoCas9, a variant that exhibits fidelity exceeding SpCas9HF1 and eSpCas9 (Kleinstiver et al., 2015; Casini et al., 2018).”
BackgroundZuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460 · cited 1×
“By contrast, LNP-delivered Cas9 mRNA and sgRNA can be quickly degraded in vivo, thus LNP is currently the most popular vector for in vivo gene editing (Zuris et al., 2015; Wang et al., 2016b; Finn et al., 2018; Qiu et al., 2021; Ju et al., 2022; Ghani et al., 2023), which has already lead to investigational new drugs…”
BackgroundAnalysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
Cho, S. W., Kim, S., Kim, Y., Kweon, J., Kim, H. S., Bae, S., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.162339.113 · Cited by 1,356 · cited 4×
“In the sgRNA extending approach, two guanine nucleotides are usually added at the 5’ end of sgRNAs (termed 5’-GGX20) (Cho et al., 2014).”
BackgroundInfluentialEnhanced proofreading governs CRISPR-Cas9 targeting accuracy
Chen, J. S., Dagdas, Y. S., Kleinstiver, B. P., Welch, M. M., Sousa, A. A., Harrington, L. B., Sternberg, S. H., Joung, J. K., Yildiz, A., & Doudna, J. A. (2017) · Nature · doi:10.1038/nature24268 · Cited by 1,168 · cited 3×
“For example, among the 134 off-target sites of one sgRNA targeting VEGFA with SpCas9, only 19, 24, and 18 of the off-target sites are also detectable with eSpCas9, SpCas9-HF1 and hypaCas9, respectively (Chen et al., 2017).”
BackgroundCRISPR/Cas9 in Genome Editing and Beyond
Wang, H., La Russa, M., & Qi, L. S. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014607 · Cited by 1,110
CCTop: An intuitive, flexible and reliable CRISPR/Cas9 target prediction tool
Stemmer, M., Thumberger, T., del Sol Keyer, M., Wittbrodt, J., & Mateo, J. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124633 · Cited by 1,088 · cited 10×
“Cas-OFFinder is more widely applicated due to its high tolerance of sgRNA length, PAM types, and the number of mismatches or bulges (Bae et al., 2014).”
MethodInfluentialRichter, M. F., Zhao, K. T., Eton, E., Lapinaite, A., Newby, G. A., Thuronyi, B. W., Wilson, C., Koblan, L. W., Zeng, J., Bauer, D. E., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0453-z · Cited by 1,020 · cited 2×
“The sgRNA-independent DNA editing is likely deposited on loci where DNA unwinds into an R-loop so single-strand genomic DNA is exposed to deaminases (Jin et al., 2020; Richter et al., 2020).”
BackgroundDigenome-seq: Genome-wide profiling of CRISPR-cas9 off-target effects in human cells
Kim, D., Bae, S., Park, J., Kim, E., Kim, S., Yu, H. R., Hwang, J., Kim, J.-I., & Kim, J.-S. (2015) · Nature Methods · doi:10.1038/nmeth.3284 · Cited by 992
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
Wu, X., Scott, D. A., Kriz, A. J., Chiu, A. C., Hsu, P. D., Dadon, D. B., Cheng, A. W., Trevino, A. E., Konermann, S., Chen, S., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2889 · Cited by 944 · cited 1×
“This method uses catalytically inactive Cas9 (dCas9), which can bind to genome DNA without introducing DSBs and detaching from the edited sites (Kuscu et al., 2014; Wu et al., 2014).”
MethodFinn, J. D., Smith, A. R., Patel, M. C., Shaw, L., Youniss, M. R., van Heteren, J., Dirstine, T., Ciullo, C., Lescarbeau, R., Seitzer, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.014 · Cited by 878 · cited 2×
“…can be quickly degraded in vivo, thus LNP is currently the most popular vector for in vivo gene editing (Zuris et al., 2015; Wang et al., 2016b; Finn et al., 2018; Qiu et al., 2021; Ju et al., 2022; Ghani et al., 2023), which has already lead to investigational new drugs in clinical trials…”
BackgroundCIRCLE-Seq: A highly sensitive in vitro screen for genome-wide CRISPR-cas9 nuclease off-targets
Tsai, S. Q., Nguyen, N. T., Malagon-Lopez, J., Topkar, V. V., Aryee, M. J., & Joung, J. K. (2017) · Nature Methods · doi:10.1038/nmeth.4278 · Cited by 814 · cited 2×
“With the presence of Cas9/sgRNA complexes, the circular DNA fragments were selectively linearized upon Cas9 nuclease cleavage before they become available for library construction and highthroughput sequencing (Tsai et al., 2017; Lv et al., 2022; Pan et al., 2022).”
BackgroundCytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos
Zuo, E., Sun, Y., Wei, W., Yuan, T., Ying, W., Sun, H., Yuan, L., Steinmetz, L. M., Li, Y., & Yang, H. (2019) · Science · doi:10.1126/science.aav9973 · Cited by 782 · cited 1×
“Although CBE and ABE greatly reduce the classic off-target effects of CRISPR/Cas9 systems, they create new formats of offtarget effects such as RNA editing and sgRNA-independent DNA editing (Grünewald et al., 2019; Jin et al., 2019; Zhou et al., 2019; Zuo et al., 2019).”
BackgroundGenome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
Kuscu, C., Arslan, S., Singh, R., Thorpe, J., & Adli, M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2916 · Cited by 777 · cited 2×
“This method uses catalytically inactive Cas9 (dCas9), which can bind to genome DNA without introducing DSBs and detaching from the edited sites (Kuscu et al., 2014; Wu et al., 2014).”
BackgroundMethodGenome-wide detection of DNA double-stranded breaks induced by engineered nucleases
Frock, R. L., Hu, J., Meyers, R. M., Ho, Y.-J., Kii, E., & Alt, F. W. (2015) · Nature Biotechnology · doi:10.1038/nbt.3101 · Cited by 673 · cited 3×
“To better detect such DSBs, LAM–HTGTS was developed (Frock et al., 2015; Hu et al., 2016).”
BackgroundMethodCytosine, but not adenine, base editors induce genome-wide off-target mutations in rice
Jin, S., Zong, Y., Gao, Q., Zhu, Z., Wang, Y., Qin, P., Liang, C., Wang, D., Qiu, J.-L., Zhang, F., et al. (2019) · Science · doi:10.1126/science.aaw7166 · Cited by 665 · cited 1×
“Although CBE and ABE greatly reduce the classic off-target effects of CRISPR/Cas9 systems, they create new formats of offtarget effects such as RNA editing and sgRNA-independent DNA editing (Grünewald et al., 2019; Jin et al., 2019; Zhou et al., 2019; Zuo et al., 2019).”
BackgroundTranscriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors
Grünewald, J., Zhou, R., Garcia, S. P., Iyer, S., Lareau, C. A., Aryee, M. J., & Joung, J. K. (2019) · Nature · doi:10.1038/s41586-019-1161-z · Cited by 663 · cited 2×
“The RNA off-target effects can be detected by RNA-seq (Grünewald et al., 2019; Zhou et al., 2019) and are believed to be transient given the short lifetime of RNA.”
BackgroundGene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA
Ramakrishna, S., Kwaku Dad, A.-B., Beloor, J., Gopalappa, R., Lee, S.-K., & Kim, H. (2014) · Genome Research · doi:10.1101/gr.171264.113 · Cited by 655 · cited 1×
“RNP electroporation exhibits higher on-target editing efficiency and lower off-target mutations than the other delivery methods (Kim et al., 2014; Ramakrishna et al., 2014).”
BackgroundDeepCRISPR: Optimized CRISPR guide RNA design by deep learning
Chuai, G., Ma, H., Yan, J., Chen, M., Hong, N., Xue, D., Zhou, C., Zhu, C., Chen, K., Duan, B., et al. (2018) · Genome biology · doi:10.1186/s13059-018-1459-4 · Cited by 641 · cited 1×
“It considers epigenetic features such as chromatin opening and DNA methylation to figure out genomewide off-target profiles (Chuai et al., 2018).”
BackgroundEfficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
Wang, M., Zuris, J. A., Meng, F., Rees, H., Sun, S., Deng, P., Han, Y., Gao, X., Pouli, D., Wu, Q., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520244113 · Cited by 624
An unbiased genome-wide analysis of zinc-finger nuclease specificity
Gabriel, R., Lombardo, A., Arens, A., Miller, J. C., Genovese, P., Kaeppel, C., Nowrouzi, A., Bartholomae, C. C., Wang, J., Friedman, G., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1948 · Cited by 526 · cited 4×
“Early studies utilize zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) for genome editing (Urnov et al., 2010; Joung and Sander, 2013; Shamshirgaran et al., 2022).”
BackgroundInfluentialA highly specific SpCas9 variant is identified by in vivo screening in yeast
Casini, A., Olivieri, M., Petris, G., Montagna, C., Reginato, G., Maule, G., Lorenzin, F., Prandi, D., Romanel, A., Demichelis, F., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4066 · Cited by 493 · cited 2×
“This screen identified four key beneficial point mutations in SpCas9, giving rise to evoCas9, a variant that exhibits fidelity exceeding SpCas9HF1 and eSpCas9 (Kleinstiver et al., 2015; Casini et al., 2018).”
BackgroundOff-target RNA mutation induced by DNA base editing and its elimination by mutagenesis
Zhou, C., Sun, Y., Yan, R., Liu, Y., Zuo, E., Gu, C., Han, L., Wei, Y., Hu, X., Zeng, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1314-0 · Cited by 482 · cited 2×
“The RNA off-target effects can be detected by RNA-seq (Grünewald et al., 2019; Zhou et al., 2019) and are believed to be transient given the short lifetime of RNA.”
BackgroundVeres, A., Gosis, B. S., Ding, Q., Collins, R., Ragavendran, A., Brand, H., Erdin, S., Cowan, C. A., Talkowski, M. E., & Musunuru, K. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.04.020 · Cited by 474 · cited 1×
“WGS analysis of off-target effects has been well documented in cell culture studies (Smith et al., 2014; Veres et al., 2014; Iyer et al., 2015).”
BackgroundNucleotide-resolution DNA double-strand break mapping by next-generation sequencing
Crosetto, N., Mitra, A., Silva, M. J., Bienko, M., Dojer, N., Wang, Q., Karaca, E., Chiarle, R., Skrzypczak, M., Ginalski, K., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2408 · Cited by 465 · cited 2×
“BLESS demonstrates a false positive rate lower than 1% (Crosetto et al., 2013; Yan et al., 2017; Kim et al., 2019), validating the accuracy of this method.”
BackgroundMethodLatest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing
Naeem, M., Majeed, S., Hoque, M. Z., & Ahmad, I. (2020) · Cells · doi:10.3390/cells9071608 · Cited by 457 · cited 1×
“In this scenario, in silico tools are useful to search for potential off-target sites in the whole genome and calculate the likelihood of an off-target editing (Naeem et al., 2020).”
BackgroundMapping the genomic landscape of CRISPR-Cas9 cleavage
Cameron, P., Fuller, C. K., Donohoue, P. D., Jones, B. N., Thompson, M. S., Carter, M. M., Gradia, S., Vidal, B., Garner, E., Slorach, E. M., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4284 · Cited by 443 · cited 1×
“To reduce such cost, scientists developed SITE-seq, a method that adds a selective biotinylation reaction on the cleaved genomic sites and leverages streptavidin pulldown to enrich these sites before sequencing (Cameron et al., 2017).”
MethodWang, X., Wang, Y., Wu, X., Wang, J., Wang, Y., Qiu, Z., Chang, T., Huang, H., Lin, R.-J., & Yee, J.-K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3127 · Cited by 442 · cited 4×
“IDLV was first designed to detect DSBs created by ZFNs and TALENs (Gabriel et al., 2011; Wang et al., 2015; Wang et al., 2021).”
BackgroundInfluentialUnbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq
Wienert, B., Wyman, S. K., Richardson, C. D., Yeh, C. D., Akcakaya, P., Porritt, M. J., Morlock, M., Vu, J. T., Kazane, K. R., Watry, H. L., et al. (2019) · Science · doi:10.1126/science.aav9023 · Cited by 434 · cited 3×
“However, because MRE11-DSB binding is transient, Discover-seq only captures DSBs that are present at the moment of sample preparation (Wienert et al., 2019).”
BackgroundHigh levels of AAV vector integration into CRISPR-induced DNA breaks
Hanlon, K. S., Kleinstiver, B. P., Garcia, S. P., Zaborowski, M. P., Volak, A., Spirig, S. E., Muller, A., Sousa, A. A., Tsai, S. Q., Bengtsson, N. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12449-2 · Cited by 431 · cited 1×
“While this property might be favored in gene supplementation applications, AAV-mediated gene editing likely exhibits the propensity to accumulate undesired off-target mutations over time (Hanlon et al., 2019; Kim et al., 2019).”
BackgroundQiu, M., Glass, Z., Chen, J., Haas, M., Jin, X., Zhao, X., Rui, X., Ye, Z., Li, Y., Zhang, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020401118 · Cited by 409 · cited 1×
“By contrast, LNP-delivered Cas9 mRNA and sgRNA can be quickly degraded in vivo, thus LNP is currently the most popular vector for in vivo gene editing (Zuris et al., 2015; Wang et al., 2016b; Finn et al., 2018; Qiu et al., 2021; Ju et al., 2022; Ghani et al., 2023), which has already lead to investigational new drugs…”
BackgroundLipid nanoparticle technology for therapeutic gene regulation in the liver
Witzigmann, D., Kulkarni, J. A., Leung, J., Chen, S., Cullis, P. R., & van der Meel, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.026 · Cited by 376 · cited 2×
“By contrast, LNP-delivered Cas9 mRNA and sgRNA can be quickly degraded in vivo, thus LNP is currently the most popular vector for in vivo gene editing (Zuris et al., 2015; Wang et al., 2016b; Finn et al., 2018; Qiu et al., 2021; Ju et al., 2022; Ghani et al., 2023), which has already lead to investigational new drugs…”
CRISPR/Cas: A powerful tool for gene function study and crop improvement
Zhang, D., Zhang, Z., Unver, T., & Zhang, B. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2020.10.003 · Cited by 373 · cited 1×
“Designing sgRNA is more convenient, programmable and cost-effective than designing DNA binding domains, thus CRISPR/Cas9 is more favored than ZFNs and TALENs and has revolutionized the biotechnology field (Zhang et al., 2021; Tran et al., 2022).”
BackgroundBLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks
Yan, W. X., Mirzazadeh, R., Garnerone, S., Scott, D., Schneider, M. W., Kallas, T., Custodio, J., Wernersson, E., Li, Y., Gao, L., et al. (2017) · Nature Communications · doi:10.1038/ncomms15058 · Cited by 369 · cited 14×
“Compared to BLESS, BLISS demands only a few thousand cells and demonstrates a higher sensitivity.”
BackgroundMethodInfluentialCasOT: A genome-wide cas9/gRNA off-target searching tool
Xiao, A., Cheng, Z., Kong, L., Zhu, Z., Lin, S., Gao, G., & Zhang, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt764 · Cited by 363 · cited 1×
“CasOT is the first exhaustive tool to predict off-target sites in userprovided reference genome, and it allows custom adjustment of several parameters including the PAM sequence and the mismatch number (Xiao et al., 2014).”
MethodSmith, C., Gore, A., Yan, W., Abalde-Atristain, L., Li, Z., He, C., Wang, Y., Brodsky, R. A., Zhang, K., Cheng, L., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.06.011 · Cited by 342 · cited 1×
“WGS analysis of off-target effects has been well documented in cell culture studies (Smith et al., 2014; Veres et al., 2014; Iyer et al., 2015).”
BackgroundPrediction of off-target activities for the end-to-end design of CRISPR guide RNAs
Listgarten, J., Weinstein, M., Kleinstiver, B. P., Sousa, A. A., Joung, J. K., Crawford, J., Gao, K., Hoang, L., Elibol, M., Doench, J. G., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0178-6 · Cited by 336 · cited 2×
“Similarly, the Elevation tool also includes DNA accessibility information to predict potential off-target sites (Listgarten et al., 2018).”
BackgroundMethodHigh-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR)
Schmidt, M., Schwarzwaelder, K., Bartholomae, C., Zaoui, K., Ball, C., Pilz, I., Braun, S., Glimm, H., & von Kalle, C. (2007) · Nature Methods · doi:10.1038/nmeth1103 · Cited by 328 · cited 1×
“selectively amplified by nested PCR for NGS analysis (Schmidt et al., 2007; Hu et al., 2016) (Figure 1C).”
MethodThe impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy
Lindeboom, R. G. H., Vermeulen, M., Lehner, B., & Supek, F. (2019) · Nature Genetics · doi:10.1038/s41588-019-0517-5 · Cited by 327 · cited 1×
“When the indels are deposited at the coding sequences of a given gene, NHEJ can cause frameshift mutations, resulting in nonsense-mediated mRNA decay and gene silencing (Wang et al., 2016a; Zischewski et al., 2017; Lindeboom et al., 2019).”
BackgroundZischewski, J., Fischer, R., & Bortesi, L. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.003 · Cited by 323 · cited 1×
“When the indels are deposited at the coding sequences of a given gene, NHEJ can cause frameshift mutations, resulting in nonsense-mediated mRNA decay and gene silencing (Wang et al., 2016a; Zischewski et al., 2017; Lindeboom et al., 2019).”
BackgroundImproving CRISPR-Cas specificity with chemical modifications in single-guide RNAs
Ryan, D. E., Taussig, D., Steinfeld, I., Phadnis, S. M., Lunstad, B. D., Singh, M., Vuong, X., Okochi, K. D., McCaffrey, R., Olesiak, M., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1199 · Cited by 280 · cited 1×
“One study incorporated 2’-O-methyl-3’-phosphonoacetate (MP) into the ribose-phosphate backbone of sgRNA and found that MP modifications at certain positions can enhance on-target specificity while dramatically reducing off-target activity (Ryan et al., 2018).”
BackgroundGenome-wide target specificities of CRISPR RNA-guided programmable deaminases
Kim, D., Lim, K., Kim, S.-T., Yoon, S.-H., Kim, K., Ryu, S.-M., & Kim, J.-S. (2017) · Nature Biotechnology · doi:10.1038/nbt.3852 · Cited by 276 · cited 1×
“Apart from the impact of sgRNA sequences, accumulative evidence showed that the specificity of Cas9 activity can be enhanced by extending or truncating sgRNAs (Cho et al., 2014; Fu et al., 2014; Kim et al., 2016; Kim et al., 2017; Liang et al., 2019).”
BackgroundHu, J., Meyers, R. M., Dong, J., Panchakshari, R. A., Alt, F. W., & Frock, R. L. (2016) · Nature Protocols · doi:10.1038/nprot.2016.043 · Cited by 263 · cited 5×
“However, because DNA translocation occurs less frequently than small DNA insertions, whether the sensitivity of LAM–HTGTS is comparable to other off-target detection methods remains questionable (Hu et al., 2016; Li et al., 2019).”
MethodResultInfluentialDelivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
Taha, E. A., Lee, J., & Hotta, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.013 · Cited by 259 · cited 1×
“Therefore, methods to deliver Cas9/sgRNA into the target cells profoundly influence its off-target effect (Lohia et al., 2022; Taha et al., 2022).”
MethodStreptococcus thermophilus CRISPR-cas9 systems enable specific editing of the human genome
Müller, M., Lee, C. M., Gasiunas, G., Davis, T. H., Cradick, T. J., Siksnys, V., Bao, G., Cathomen, T., & Mussolino, C. (2016) · Molecular Therapy · doi:10.1038/mt.2015.218 · Cited by 254
Partial DNA-guided Cas9 enables genome editing with reduced off-target activity
Yin, H., Song, C.-Q., Suresh, S., Kwan, S.-Y., Wu, Q., Walsh, S., Ding, J., Bogorad, R. L., Zhu, L. J., Wolfe, S. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2559 · Cited by 240 · cited 1×
“The replacement of ribonucleotides by deoxyribonucleotides also reduced off-target effects (Yin et al., 2018).”
BackgroundA genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture
O'Geen, H., Henry, I. M., Bhakta, M. S., Meckler, J. F., & Segal, D. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv137 · Cited by 219 · cited 1×
“Nevertheless, accumulative studies have proved that sgRNAindependent off-target effects also exist, urging unbiased experimental detection and validation (Richter et al., 2020; O’Geen et al., 2015).”
BackgroundCas9-chromatin binding information enables more accurate CRISPR off-target prediction
Singh, R., Kuscu, C., Quinlan, A., Qi, Y., & Adli, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv575 · Cited by 217 · cited 10×
“Cas-OFFinder is more widely applicated due to its high tolerance of sgRNA length, PAM types, and the number of mismatches or bulges (Bae et al., 2014).”
MethodInfluentialGenome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq
Kim, D., Kim, S., Kim, S., Park, J., & Kim, J.-S. (2016) · Genome Research · doi:10.1101/gr.199588.115 · Cited by 208 · cited 2×
“Apart from the impact of sgRNA sequences, accumulative evidence showed that the specificity of Cas9 activity can be enhanced by extending or truncating sgRNAs (Cho et al., 2014; Fu et al., 2014; Kim et al., 2016; Kim et al., 2017; Liang et al., 2019).”
BackgroundMethodStructural basis for Cas9 off-target activity
Pacesa, M., Lin, C.-H., Cléry, A., Saha, A., Arantes, P. R., Bargsten, K., Irby, M. J., Allain, F. H.-T., Palermo, G., Cameron, P., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.026 · Cited by 198
Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity
Cromwell, C. R., Sung, K., Park, J., Krysler, A. R., Jovel, J., Kim, S. K., & Hubbard, B. P. (2018) · Nature Communications · doi:10.1038/s41467-018-03927-0 · Cited by 190 · cited 1×
“[N-Me]) or locked nucleic acids (LNA) into the sgRNAs also reduces the kinetics of Cas9 nuclease reactivity, thereby improving the specificity of genome editing (Cromwell et al., 2018).”
BackgroundOff-target mutations are rare in Cas9-modified mice
Iyer, V., Shen, B., Zhang, W., Hodgkins, A., Keane, T., Huang, X., & Skarnes, W. C. (2015) · Nature Methods · doi:10.1038/nmeth.3408 · Cited by 185 · cited 1×
“WGS analysis of off-target effects has been well documented in cell culture studies (Smith et al., 2014; Veres et al., 2014; Iyer et al., 2015).”
BackgroundFu, Y.-W., Dai, X.-Y., Wang, W.-T., Yang, Z.-X., Zhao, J.-J., Zhang, J.-P., Wen, W., Zhang, F., Oberg, K. C., Zhang, L., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1251 · Cited by 180 · cited 1×
“By contrast, the error-prone NHEJ mechanism introduces small insertions and deletions (indels) and the exact sequence changes are unpredictable and uncontrollable (Fu et al., 2021).”
BackgroundEvaluating and enhancing target specificity of gene-editing nucleases and deaminases
Kim, D., Luk, K., Wolfe, S. A., & Kim, J.-S. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111730 · Cited by 171 · cited 8×
“One such labeling tool is called the integrase-defective lentiviral vectors (IDLV), which displays the propensity to integrate into the vicinity of DSBs (Wang et al., 2015; Kim et al., 2019).”
BackgroundMethodInfluentialRationally designed APOBEC3B cytosine base editors with improved specificity
Jin, S., Fei, H., Zhu, Z., Luo, Y., Liu, J., Gao, S., Zhang, F., Chen, Y.-H., Wang, Y., & Gao, C. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.005 · Cited by 159 · cited 1×
“The sgRNA-independent DNA editing is likely deposited on loci where DNA unwinds into an R-loop so single-strand genomic DNA is exposed to deaminases (Jin et al., 2020; Richter et al., 2020).”
BackgroundFlashFry: A fast and flexible tool for large-scale CRISPR target design
McKenna, A., & Shendure, J. (2018) · BMC Biology · doi:10.1186/s12915-018-0545-0 · Cited by 152 · cited 1×
“It is a highthroughput tool which can also provide information about GC contents and on/off-target scores (McKenna and Shendure, 2018).”
BackgroundGenome-wide profiling of adenine base editor specificity by EndoV-seq
Liang, P., Xie, X., Zhi, S., Sun, H., Zhang, X., Chen, Y., Chen, Y., Xiong, Y., Ma, W., Liu, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07988-z · Cited by 148 · cited 3×
“Such DNA cuts can be detected by sequencing using an experimental platform similar to Digenome-seq (Liang et al., 2019).”
BackgroundMethodGenome-wide identification of CRISPR/Cas9 off-targets in human genome
Duan, J., Lu, G., Xie, Z., Lou, M., Luo, J., Guo, L., & Zhang, Y. (2014) · Cell Research · doi:10.1038/cr.2014.87 · Cited by 137 · cited 1×
“However, other publications observed a much lower validation rate (Cencic et al., 2014; Duan et al., 2014; Tsai et al., 2015).”
BackgroundFerrari, S., Jacob, A., Cesana, D., Laugel, M., Beretta, S., Varesi, A., Unali, G., Conti, A., Canarutto, D., Albano, L., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.09.001 · Cited by 133 · cited 1×
“Empowered by the robust transduction ability of lentivirus in certain cell types, this method can detect off-target effects in cell types that are otherwise difficult to transfect (Ferrari et al., 2022).”
MethodProtospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage
Cencic, R., Miura, H., Malina, A., Robert, F., Ethier, S., Schmeing, T. M., Dostie, J., & Pelletier, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109213 · Cited by 117 · cited 1×
“However, other publications observed a much lower validation rate (Cencic et al., 2014; Duan et al., 2014; Tsai et al., 2015).”
BackgroundTools for efficient genome editing; ZFN, TALEN, and CRISPR
Shamshirgaran, Y., Liu, J., Sumer, H., Verma, P. J., & Taheri-Ghahfarokhi, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2301-5_2 · Cited by 114 · cited 1×
“Early studies utilize zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) for genome editing (Urnov et al., 2010; Joung and Sander, 2013; Shamshirgaran et al., 2022).”
BackgroundDelivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles
Evers, M. J. W., Du, W., Yang, Q., Kooijmans, S. A. A., Vink, A., van Steenbergen, M., Vader, P., de Jager, S. C. A., Fuchs, S. A., Mastrobattista, E., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.027 · Cited by 113 · cited 1×
“Similar to RNP electroporation, Cas9 mRNA and sgRNA can also be delivered into cells via electroporation or liposome-based vectors (Evers et al., 2022; Yu et al., 2023) to improved genome editing fidelity.”
BackgroundDIG-Seq: A genome-wide CRISPR off-target profiling method using chromatin DNA
Kim, D., & Kim, J.-S. (2018) · Genome Research · doi:10.1101/gr.236620.118 · Cited by 108 · cited 2×
“The comparative study between Digenome-seq and DIG-seq strongly indicated the influence of chromatin states on the offtarget activity (Kim and Kim, 2018).”
MethodResultTools for experimental and computational analyses of off-target editing by programmable nucleases
Bao, X. R., Pan, Y., Lee, C. M., Davis, T. H., & Bao, G. (2021) · Nature Protocols · doi:10.1038/s41596-020-00431-y · Cited by 106 · cited 1×
“CRISPR/Cas9 off-target effects can be predicted by in silico tools, which are usually open-source online software that can be conveniently accessed via internet (Bao et al., 2021).”
BackgroundLu, B., Javidi-Parsijani, P., Makani, V. S., Mehraein‐Ghomi, F., Sarhan, W. M., Sun, D., Yoo, K. W., Atala, Z., Lyu, P., & Atala, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz093 · Cited by 100 · cited 1×
“AAV-delivered gene expression is known to last for years in terminally differentiated cell types (Lu et al., 2019).”
BackgroundBiased and unbiased methods for the detection of off-target cleavage by CRISPR/Cas9: An overview
Martin, F., Sánchez-Hernández, S., Gutiérrez-Guerrero, A., Pinedo-Gomez, J., & Benabdellah, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091507 · Cited by 92 · cited 1×
“The disadvantages of IDLV include its low sensitivity and high false positive rate, probably due to non-specific IDLV integration and PCR amplification (Martin et al., 2016).”
BackgroundLv, W., Pan, X., Han, P., Wang, Z., Feng, W., Xing, X., Wang, Q., Qu, K., Zeng, Y., Zhang, C., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.817 · Cited by 90 · cited 1×
“With the presence of Cas9/sgRNA complexes, the circular DNA fragments were selectively linearized upon Cas9 nuclease cleavage before they become available for library construction and highthroughput sequencing (Tsai et al., 2017; Lv et al., 2022; Pan et al., 2022).”
Defining genome-wide CRISPR–Cas genome-editing nuclease activity with GUIDE-seq
Malinin, N. L., Lee, G., Lazzarotto, C. R., Li, Y., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Iafrate, A. J., Le, L. P., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00626-x · Cited by 87 · cited 1×
“The integrated dsODNs provide templates for targeted PCR amplification and sequencing of the tagged DNA fragments (Tsai et al., 2015; Malinin et al., 2021; Yaish et al., 2022) (Figure 1B).”
BackgroundKumar, N., Stanford, W., de Solis, C., Aradhana, Abraham, N. D., Dao, T.-M. J., Thaseen, S., Sairavi, A., Gonzalez, C. U., & Ploski, J. E. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00413 · Cited by 79 · cited 1×
“For example, in contrast to SpCas9, which uses a relatively common 5’-NGG-3’ PAM, the SaCas9 that is derived from Staphylococcus aureus requires a more complicated PAM sequence of 5’-NGGRRT3’ (Kumar et al., 2018).”
BackgroundDetect-seq reveals out-of-protospacer editing and target-strand editing by cytosine base editors
Lei, Z., Meng, H., Lv, Z., Liu, M., Zhao, H., Wu, H., Zhang, X., Liu, L., Zhuang, Y., Yin, K., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01172-w · Cited by 67 · cited 2×
“Similar to EndoV-seq, Detect-seq measures CBE off-target effects by tracking its reaction intermediates (Lei et al., 2021).”
BackgroundMethodAdvances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing
Li, J., Hong, S., Chen, W., Zuo, E., & Yang, H. (2019) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.002 · Cited by 63 · cited 2×
“The advantage of this method is the ability to detect chromosomal translocations that may be missed by other methods (Hu et al., 2016; Li et al., 2019; Xu et al., 2023).”
ResultWu, Y., Ren, Q., Zhong, Z., Liu, G., Han, Y., Bao, Y., Liu, L., Xiang, S., Liu, S., Tang, X., et al. (2022) · Plant Biotechnology Journal · doi:10.1111/pbi.13838 · Cited by 56 · cited 1×
“ABE catalyzes the editing from adenine to guanine and CBE converts cytosine to thymine (Komor et al., 2016; Gaudelli et al., 2017; Wu et al., 2022).”
BackgroundGenome-wide detection of CRISPR editing in vivo using GUIDE-tag
Liang, S.-Q., Liu, P., Smith, J. L., Mintzer, E., Maitland, S., Dong, X., Yang, Q., Lee, J., Haynes, C. M., Zhu, L. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28135-9 · Cited by 54 · cited 8×
“When the indels are deposited at the coding sequences of a given gene, NHEJ can cause frameshift mutations, resulting in nonsense-mediated mRNA decay and gene silencing (Wang et al., 2016a; Zischewski et al., 2017; Lindeboom et al., 2019).”
BackgroundMethodInfluentialTran, N. T., Danner, E., Li, X., Graf, R., Lebedin, M., de la Rosa, K., Kühn, R., Rajewsky, K., & Chu, V. T. (2022) · Science Advances · doi:10.1126/sciadv.abm9106 · Cited by 49 · cited 1×
“Designing sgRNA is more convenient, programmable and cost-effective than designing DNA binding domains, thus CRISPR/Cas9 is more favored than ZFNs and TALENs and has revolutionized the biotechnology field (Zhang et al., 2021; Tran et al., 2022).”
BackgroundJacquin, A. L. S., Odom, D. T., & Lukk, M. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz019 · Cited by 46 · cited 1×
“Crisflash is a tool for both sgRNA design and latent off-target discovery, which is over an order of magnitude faster than other software (Jacquin et al., 2019).”
MethodJu, H., Kim, D., & Oh, Y. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.07.005 · Cited by 44 · cited 1×
“By contrast, LNP-delivered Cas9 mRNA and sgRNA can be quickly degraded in vivo, thus LNP is currently the most popular vector for in vivo gene editing (Zuris et al., 2015; Wang et al., 2016b; Finn et al., 2018; Qiu et al., 2021; Ju et al., 2022; Ghani et al., 2023), which has already lead to investigational new drugs…”
BackgroundMassively targeted evaluation of therapeutic CRISPR off-targets in cells
Pan, X., Qu, K., Yuan, H., Xiang, X., Anthon, C., Pashkova, L., Liang, X., Han, P., Corsi, G. I., Xu, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31543-6 · Cited by 42 · cited 2×
“A primary limitation of GUIDE-seq is relevant to the low delivery efficiency of dsODNs into cells, which results in detection of only 30%–50% of all the DSBs (Tsai et al., 2015; Pan et al., 2022).”
BackgroundCromer, M. K., Majeti, K. R., Rettig, G. R., Murugan, K., Kurgan, G. L., Bode, N. M., Hampton, J. P., Vakulskas, C. A., Behlke, M. A., & Porteus, M. H. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.011 · Cited by 42 · cited 2×
“Because good ChIP-grade MRE11 antibodies are available and there is no need to deliver any exogenous components to the body, Discoverseq is broadly applicable for various types of tissue or cell samples (Wienert et al., 2019; Cromer et al., 2023).”
BackgroundMethodLipid Nanoparticle Delivery of Chemically Modified NGF R100W mRNA Alleviates Peripheral Neuropathy
Yu, X., Yang, Z., Zhang, Y., Xia, J., Zhang, J., Han, Q., Yu, H., Wu, C., Xu, Y., Xu, W., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202127 · Cited by 38 · cited 1×
“Similar to RNP electroporation, Cas9 mRNA and sgRNA can also be delivered into cells via electroporation or liposome-based vectors (Evers et al., 2022; Yu et al., 2023) to improved genome editing fidelity.”
BackgroundVeres, A., Gosis, B. S., Ding, Q., Collins, R., Ragavendran, A., Brand, H., Erdin, S., Cowan, C. A., Talkowski, M. E., & Musunuru, K. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.07.009 · Cited by 37
Lohia, A., Sahel, D. K., Salman, M., Singh, V., Mariappan, I., Mittal, A., & Chitkara, D. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.02.001 · Cited by 33 · cited 1×
“Therefore, methods to deliver Cas9/sgRNA into the target cells profoundly influence its off-target effect (Lohia et al., 2022; Taha et al., 2022).”
MethodGhani, M. W., Iqbal, A., Ghani, H., Bibi, S., Wang, Z., & Pei, R. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02610d · Cited by 33 · cited 1×
“By contrast, LNP-delivered Cas9 mRNA and sgRNA can be quickly degraded in vivo, thus LNP is currently the most popular vector for in vivo gene editing (Zuris et al., 2015; Wang et al., 2016b; Finn et al., 2018; Qiu et al., 2021; Ju et al., 2022; Ghani et al., 2023), which has already lead to investigational new drugs…”
BackgroundKwon, J., Kim, M., Hwang, W., Jo, A., Hwang, G.-H., Jung, M., Kim, U. G., Cui, G., Kim, H., Eom, J.-H., et al. (2023) · Genome biology · doi:10.1186/s13059-022-02842-4 · Cited by 24 · cited 10×
“The accuracy and sensitivity of WGS in off-target detection is determined by sequencing depth, thus when there is a demand to determine low-frequency off-target sites, WGS would become expensive.”
BackgroundMethodInfluentialAPOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNA
Niemietz, C., Nadzemova, O., Zibert, A., & Schmidt, H. H.-J. (2020) · Amyloid · doi:10.1080/13506129.2019.1681392 · Cited by 22 · cited 1×
“Nevertheless, accumulative studies have proved that sgRNAindependent off-target effects also exist, urging unbiased experimental detection and validation (Richter et al., 2020; O’Geen et al., 2015).”
BackgroundYaish, O., Asif, M., & Orenstein, Y. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac157 · Cited by 19
The epigenome editors: How tools such as CRISPR offer new details about epigenetics
Willyard, C. (2017) · Nature Medicine · doi:10.1038/nm0817-900 · Cited by 13 · cited 2×
“However, epigenetic editors could potentially exert off-target effects at the epigenome level (Willyard, 2017), which should be carefully evaluated by ChIP-seq-based analysis.”
BackgroundGenome-wide CRISPR off-target DNA break detection by the BLISS method
Ballarino, R., Bouwman, B. A. M., & Crosetto, N. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-0687-2_15 · Cited by 8 · cited 1×
“BLISS ligates DSB ends with adapters containing the T7 promoter, so the tagged DNA fragments can be linearly amplified via T7-mediated transcription before sequencing (Yan et al., 2017; Ballarino et al., 2021).”
MethodCRISPR off-target analysis platforms
Xu, C. L., Ruan, M. Z., Ragi, S. D., & Tsang, S. H. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2651-1_26 · Cited by 6 · cited 1×
“The advantage of this method is the ability to detect chromosomal translocations that may be missed by other methods (Hu et al., 2016; Li et al., 2019; Xu et al., 2023).”
Detection of CRISPR/Cas9-Generated off-target effect by integration-defective lentiviral vector
Wang, X., Wu, Y., & Yee, J.-K. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-0687-2_14 · Cited by 5
Cited by
Lu, P., Ruan, D., Huang, M., Tian, M., Zhu, K., Gan, Z., & Xiao, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01852-x · Cited by 667
Recent advances of CRISPR-based genome editing for enhancing staple crops
Chen, F., Chen, L., Yan, Z., Xu, J., Feng, L., He, N., Guo, M., Zhao, J., Chen, Z., Chen, H., et al. (2024) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1478398 · Cited by 179
“High-fi delity Cas9 variants, such as eSpCas9, SpCas9-HF1 and FrCas9, have been engineered to enhance precision by reducing nonspeci fi c DNA interactions (Guo et al., 2023; He et al., 2024).”
BackgroundAljabali, A. A. A., El‐Tanani, M., & Tambuwala, M. M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105338 · Cited by 232
Dias, J., García, J., Agliardi, G., & Roddie, C. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101250 · Cited by 138
Recent advancements in reducing the off-target effect of CRISPR/Cas9 genome editing
Asmamaw Mengstie, M., Teshome Azezew, M., Asmamaw Dejenie, T., Teshome, A. A., Tadele Admasu, F., Behaile Teklemariam, A., Tilahun Mulu, A., Mekonnen Agidew, M., Adugna, D. G., Geremew, H., et al. (2024) · Biologics: Targets and Therapy · doi:10.2147/btt.s429411 · Cited by 91
“14 Studies have also shown that chemical modifications at particular locations in the guide sequences can significantly increase the specificity and flexibility of CRISPR-Cas systems for the precise editing of genes.”
Background
Metadata
- Authors
- Guo, C., Ma, X., Gao, F., & Guo, Y.
- Affiliations
- Peking University (CN)
- Capital Medical University (CN)
- Corresponding author
- Gao, Fei
- Guo, Yuxuan
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2023-03-09
- Volume
- 11
- Pages
- 1143157-1143157
- ISSN
- 2296-4185 (ISSN-L)
- PMC
- PMC10034092
- OpenAlex
- W4323666400
- Cited by
- 704
- References
- 108
- Citations by year
- 2026: 225 · 2025: 290 · 2024: 154 · 2023: 35
- FWCI
- 17.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82100349, 82222006, 32100660, 82170367)
- Beijing Nova Program (Z211100002121003, 20220484205)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, off-target effects, genome editing, gene therapy, Cas9 variants
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
